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Foreword
As the largest organ of the body, the skin performs multiple critical functions, such as serving as the primary barrier to the external environment. For this reason, the skin is often exposed to potentially hazardous agents, including chemicals, which may contribute to the onset of a spectrum of adverse health effects ranging from localized damage (e.g., irritant contact dermatitis and corrosion) to induction of immune-mediated responses (e.g., allergic contact dermatitis and pulmonary responses), or systemic toxicity (e.g., neurotoxicity and hepatoxicity). Understanding the hazards related to skin contact with chemicals is a critical component of modern occupational safety and health programs.
In 2009, the National Institute for Occupational Safety and Health (NIOSH) published Current Intelligence Bulletin (CIB) 61 -A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009-147] . This document provides the scientific rationale and framework for the assignment of multiple hazard-specific skin notations (SK) that clearly distinguish between the systemic effects, direct (localized) effects, and immune-mediated responses caused by skin contact with chemicals. The key step within assignment of the hazard-specific SK is the determination of the hazard potential of the substance, or its potential for causing adverse health effects as a result of skin exposure. This determination entails a health hazard identification process that involves use of the following:
• Scientific data on the physicochemical properties of a chemical • Data on human exposures and health effects • Empirical data from in vivo and in vitro laboratory testing • Computational techniques, including predictive algorithms and mathematical models that describe a selected process (e.g., skin permeation) by means of analytical or numerical methods.
This Skin Notation Profile provides the SK assignments and supportive data for tetraethyl dithionopyrophosphate (TEDP). In particular, this document evaluates and summarizes the literature describing the hazard potential of the substance and its assessment according to the scientific rationale and framework outlined in CIB 61. In meeting this objective, this Skin Notation Profile intends to inform the audience-mostly occupational health practitioners, researchers, policy-and decision-makers, employers, and workers in potentially hazardous workplaces-so that improved risk-management practices may be developed to better protect workers from the risks of skin contact with the chemicals of interest. 
Glossary
Absorption-The transport of a chemical from the outer surface of the skin into both the skin and systemic circulation (including penetration, permeation, and resorption).
Acute exposure-Contact with a chemical that occurs once or for only a short period of time.
Cancer-Any one of a group of diseases that occurs when cells in the body become abnormal and grow or multiply out of control.
Contaminant-A chemical that is (1) unintentionally present within a neat substance or mixture at a concentration less than 1.0% or (2) recognized as a potential carcinogen and present within a neat substance or mixture at a concentration less than 0.1%.
Cutaneous (or percutaneous)-Referring to the skin (or through the skin).
Dermal-Referring to the skin.
Dermal contact-Contact with (touching) the skin.
Direct effects-Localized, non-immune-mediated adverse health effects on the skin, including corrosion, primary irritation, changes in skin pigmentation, and reduction/disruption of the skin barrier integrity, occurring at or near the point of contact with chemicals.
Immune-mediated responses-Responses mediated by the immune system, including allergic responses.
Sensitization-A specific immune-mediated response that develops following exposure to a chemical, which, upon re-exposure, can lead to allergic contact dermatitis (ACD) or other immune-mediated diseases such as asthma, depending on the site and route of reexposure.
Substance-A chemical.
Systemic effects-Systemic toxicity associated with skin absorption of chemicals after exposure of the skin. In addition, special appreciation is expressed to the following individuals for serving as independent, external reviewers and providing comments that contributed to the development or improvement of this document: 
Purpose
This skin notation profile presents (1) a brief summary of epidemiological and toxicological data associated with skin contact with TEDP and (2) the rationale behind the hazard-specific skin notation (SK) assignment for TEDP. The SK assignment is based on the scientific rationale and logic outlined in the Current Intelligence Bulletin (CIB considered from studies of humans, animals, or appropriate modeling systems that are relevant to assessing the effects of dermal exposure to TEDP.
Overview of SK Assignment
TEDP is potentially capable of causing numerous adverse health effects following skin contact. A critical review of available data has resulted in the following SK assignment for TEDP: SK: SYS (FATAL)-DIR (IRR). Table 1 provides an overview of the critical effects and data used to develop the SK assignment for TEDP. 
Systemic Toxicity from Skin Exposure (SK: SYS)
No toxicokinetic studies were identified in humans or animals that estimated the degree of TEDP absorption through the skin following dermal. The potential of TEDP to pose a skin absorption hazard was also evaluated, with use of a predictive algorithm for estimating and evaluating the health hazards of dermal exposure to substances [NIOSH 2009 ]. The evaluation method compares an estimated dose accumulated in the body from skin absorption and an estimated dose from respiratory absorption associated with a reference occupational exposure limit. On the basis of this algorithm, a ratio of the skin dose to the inhalation dose (SI ratio) of 0.43 was calculated for TEDP. An SI ratio of ≥0.1 indicates that skin absorption may significantly contribute to the overall body burden of a substance [NIOSH 2009 ]; therefore, TEDP is considered to be absorbed through the skin following dermal exposure. Additional information on the SI ratio and the variables used in its calculation are included in the appendix.
No estimate of the human dermal lethal dose (LD Lo ) was identified for TEDP. Dermal LD 50 (the dose resulting in 50% mortality in the exposed animals) values reported ranged from 65 milligrams per kilogram (mg/kg) for male rats exposed for 7 days to 262 mg/kg for male rats exposed for 4 hours ( No epidemiological studies, case reports or occupational exposure studies, and no repeatdose, subchronic or chronic toxicity studies in animals were identified that evaluated the potential of TEDP to cause systemic effects following dermal exposure. However, dermal contact with TEDP at low levels used in the acute dermal toxicity studies [Kimmerle and Klimmer 1974] resulted in depression of cholinesterase (ChE) activity in peripheral and central nervous systems. This effect is consistent with the known mode of action of organophosphates, including TEDP. Kimmerle and Klimmer [1974] also reported ChE inhibition following oral and inhalation exposures of short-term or longer-term duration, indicating that the effect is not route specific.
No standard toxicity or specialty studies evaluating biological system/function specific effects (including reproductive and developmental effects and immunotoxicity) were identified following dermal exposure to TEDP. No epidemiological studies or animal bioassays were identified that investigated the carcinogenic potential of TEDP following dermal exposure. studies, with support from inhalation and oral studies, indicate that TEDP has the potential to cause ChE inhibition following repeated or prolonged dermal exposure. Therefore, on the basis of the data for this assessment, TEDP is assigned the SK: SYS (FATAL) notation.
Direct Effects on Skin (SK: DIR)
No human or animal in vivo studies for corrosivity of TEDP or in vitro tests for corrosivity using human or animal skin models or in vitro tests of skin integrity using cadaver skin were identified. In the acute dermal toxicity study conducted by Scientific Associates [1950] , application of 0.005 to 0.124 mL/kg of TEDP [corresponding to 6 to 148 mg/kg] was applied to rat skin for an unspecified duration, and caused slight effects on the skin of rats as evidence by mild redness without edema or other untoward visual reactions. In rabbits, Kimmerle and Klimmer [1974] reported that application of cotton pads treated with 100 mg of TEDP to the skin inside the auricles of two rabbits under adhesive bandage for 24 hr caused no skin effects. However, the amount applied to rats in the Kimmerle and Klimmer [1974] study, up to 100 mg, is much lower than the 500 mg required for a standard skin irritation test. Additionally, the Scientific Associates [1950] found that the oral LD 50 in rabbits was twice that of rats suggesting that there might be a species difference in dose response.
Limited data identified from an acute dermal toxicity study [Scientific Associates 1950] indicate that TEDP has the potential to cause skin irritation on prolonged contact with the skin. Therefore, on the basis of the data for this assessment, TEDP is assigned the SK: DIR (IRR) notation.
Immune-mediated Responses (SK: SEN)
No occupational exposure studies or diagnostic (human patch) tests, and no predictive tests in animals (for example, guinea pig maximization tests, Buehler tests, murine local lymph node assays, or mouse ear swelling tests), or any other studies were identified that evaluated the potential of the substance to cause skin sensitization. Therefore, on the basis of the data for this assessment, TEDP is not assigned the SK: SEN notation.
Summary
Although no in vivo or in vitro toxicokinetic data were identified for humans or animals that evaluated the potential of TEDP to be absorbed through the skin following dermal exposure, the weight of evidence from acute toxicity data in animals exposure studies or case reports, and no repeated-dose or long-term dermal exposure studies in animals were identified that evaluated the potential of TEDP to cause systemic effects, acute dermal toxicity studies, with support from inhalation and oral studies, indicate that TEDP has the potential to cause ChE inhibition following repeated or prolonged dermal exposure. Limited data identified from an acute dermal toxicity study [Scientific Associates 1950] indicate that TEDP has the potential to cause skin irritation on prolonged contact with the skin. No diagnostic (human patch) tests and no predictive tests in animals were identified that investigated the potential of TEDP to cause skin sensitization. Therefore, on the basis of these assessments, TEDP is assigned a composite skin notation of SK: SYS (FATAL)-DIR (IRR). 
Equation 3: Determination of Inhalation Dose
Inhalation dose = OEL × Inhalation volume × RF = OEL (mg/m 3 ) × 10 m 3 × 0.75
The final step is to compare the calculated skin and inhalation doses and to present the result as a ratio of skin dose to inhalation dose (the SI ratio). This ratio quantitatively indicates (1) the significance of dermal absorption as a route of occupational exposure to the substance and (2) the contribution of dermal uptake to systemic toxicity. If a substance has an SI ratio greater than or equal to 0.1, it is considered a skin absorption hazard. Table A1 summarizes the data applied in the previously described equations to determine the SI ratio for TEDP. The calculated SI ratio was 0.43. On the basis of these results, TEDP is predicted to represent a skin absorption hazard. 
Calculation

